Variations in L-selectin ligand expression in the luteal-phase endometrium after final oocyte maturation with human chorionic gonadotropin compared with a gonadotropin-releasing hormone agonist.
Final oocyte maturation was achieved by using hCG or two doses of leuprolide acetate in 16 oocyte donors after a GnRH antagonist protocol. Administration of hCG was associated with a statistical trend toward increased L-selectin ligand expression in the endometrium on postretrieval day 5, compared with the leuprolide acetate group.
Lipari
Christopher W
CW
Department of Gynecology and Obstetrics, Johns Hopkins Hospital, Baltimore, Maryland, USA. clipari1@jhmi.edu
Zhao
Yulian
Y
King
Jeremy A
JA
Alexander
Carolyn J
CJ
Bankowski
Brandon B
BB
Lai
Tsung-Hsuan
TH
Garcia
Jairo
J
Vlahos
Nikos P
NP
D000328:Adult; D006063:Chorionic Gonadotropin / Q000008:administration & dosage*; D004717:Endometrium / Q000187:drug effects / Q000378:metabolism*; D005260:Female; D005300:Fertility Agents, Female / Q000008:administration & dosage; D005786:Gene Expression Regulation / Q000502:physiology; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists*; D006801:Humans; D019041:L-Selectin / Q000378:metabolism*; D016729:Leuprolide / Q000008:administration & dosage*; D008183:Luteal Phase; D009865:Oocytes / Q000187:drug effects / Q000378:metabolism*; D010062:Ovulation Induction / Q000379:methods*
D006063:Chorionic Gonadotropin; D005300:Fertility Agents, Female; D019041:L-Selectin; D007987:Gonadotropin-Releasing Hormone; D016729:Leuprolide